281 related articles for article (PubMed ID: 30429221)
1. Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-X
Yoon MK; Kim BY; Lee JY; Ha JH; Kim SA; Lee DH; Lee MS; Lee MK; Choi JS; Cho JH; Kim JH; Kim S; Song J; Park SG; Park BC; Bae KH; Choi SU; Chi SW
J Biol Chem; 2018 Dec; 293(51):19546-19558. PubMed ID: 30429221
[TBL] [Abstract][Full Text] [Related]
2. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
Rajan S; Choi M; Baek K; Yoon HS
Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
4. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL.
Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A
BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046
[TBL] [Abstract][Full Text] [Related]
5. The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.
Matissek KJ; Mossalam M; Okal A; Lim CS
Mol Pharm; 2013 Oct; 10(10):3592-602. PubMed ID: 23968395
[TBL] [Abstract][Full Text] [Related]
6. Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis.
Liu T; Roh SE; Woo JA; Ryu H; Kang DE
Cell Death Dis; 2013 Jan; 4(1):e476. PubMed ID: 23348590
[TBL] [Abstract][Full Text] [Related]
7. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Shin JS; Ha JH; Chi SW
Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
[TBL] [Abstract][Full Text] [Related]
8. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
9. E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.
Vuillier C; Lohard S; Fétiveau A; Allègre J; Kayaci C; King LE; Braun F; Barillé-Nion S; Gautier F; Dubrez L; Gilmore AP; Juin PP; Maillet L
EMBO Rep; 2018 Feb; 19(2):234-243. PubMed ID: 29233828
[TBL] [Abstract][Full Text] [Related]
10. Effect of UV Stress on the Structure and Function of Pro-apoptotic Bid and Anti-apoptotic Bcl-xl proteins.
Bera A; Singh S; D'Souza JS; Hosur RV; Mishra P
Chembiochem; 2023 Mar; 24(5):e202200682. PubMed ID: 36597005
[TBL] [Abstract][Full Text] [Related]
11. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
12. Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells.
Li R; Boehm AL; Miranda MB; Shangary S; Grandis JR; Johnson DE
Neoplasia; 2007 Oct; 9(10):801-11. PubMed ID: 17971900
[TBL] [Abstract][Full Text] [Related]
13. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
14. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
[TBL] [Abstract][Full Text] [Related]
15. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the interaction between DJ-1 and Bcl-X
Lee MK; Lee MS; Bae DW; Lee DH; Cha SS; Chi SW
Biochem Biophys Res Commun; 2018 Jan; 495(1):1067-1073. PubMed ID: 29175327
[TBL] [Abstract][Full Text] [Related]
17. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
[TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence-based identification of octenidine as a Bcl-xL inhibitor.
Bui ATN; Son H; Park S; Oh S; Kim JS; Cho JH; Hwang HJ; Kim JH; Yi GS; Chi SW
Biochem Biophys Res Commun; 2022 Jan; 588():97-103. PubMed ID: 34953212
[TBL] [Abstract][Full Text] [Related]
19. Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL.
Yao Y; Bobkov AA; Plesniak LA; Marassi FM
Biochemistry; 2009 Sep; 48(36):8704-11. PubMed ID: 19670908
[TBL] [Abstract][Full Text] [Related]
20. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
